Key references: Attention deficit hyperactivity disorder in young people and adults

  • Bolea-Alamanac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, et al. Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2014;28(3):179–203. https://www.ncbi.nlm.nih.gov/pubmed/24526134
  • Canadian ADHD Resource Alliance (CADDRA). Canadian ADHD practice guidelines. 4th ed. Toronto, ON: CADDRA; 2018. http://www.caddra.ca/canadian-adhd-practice-guidelines/
  • Kooij JJS, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balazs J, et al. Updated European consensus statement on diagnosis and treatment of adult ADHD. Eur Psychiatry 2019;56:14–34. https://www.ncbi.nlm.nih.gov/pubmed/30453134
  • National Institute for Health and Clinical Excellence (NICE). Attention deficit hyperactivity disorder: diagnosis and management (NG87). London: NICE; 2018. https://www.nice.org.uk/guidance/NG87